Significant capital injections into Vicore Pharma and Anocca

Despite challenges on the capital markets, biotech companies Vicore Pharma and Anocca have recently completede two significant capital rounds. Their successful capital raises are a sign that investors still see potential in prominent biotech companies. BioStock takes closer look at these two funding rounds and what they mean for the companies.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/06/significant-capital-injections-into-vicore-pharma-and-anocca/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se